Proper blood pressure monitoring is a matter of life and death for patients diagnosed with hypertension. For many patients, treatment cost and complex testing regimens can make proper adherence a challenge.
Deaths from heart disease are dropping, but deaths related to hypertension and arrhythmias are on the rise, according to a new government study. The study was published in the Nov. 19 issue of the Journal of the American Medical Association, a cardiovascular disease theme issue. Findings were released early to coincide with presentation at the annual meeting of the American Heart Association, held from Nov. 15 to 19 in Chicago.
The most common cause of sudden cardiac death in young people is hypertrophic cardiomyopathy, an inherited condition that can lead to heart failure, angina, arrhythmia and sudden cardiac death. There is no medical treatment shown to halt or reverse the progression of the disease—just palliative care or surgery.
In the Hollywood version of the heart attack, patients clutch their chests, gasp for air, and often keel over. Real life isn’t usually like that. But the problem for cardiologists and other physicians whose patients have cardiac events, is that the patient may not realize he or she has had one.
Recent updates by the 8th Joint National Committee (JNC 8), the American and International Societies of Hypertension (ASH-ISH), and KDIGO recommend target blood pressure of less than 140/90 mm Hg for most individuals, including those with CKD.
Two major sets of hypertension guidelines released in 2014 contain more common threads than differences, and are intended to serve different purposes. Clinicians seeking guidance for managing hypertension in chronic kidney disease (CKD) can look for this common ground to avoid "guideline overload."